Study Findings from First Medical Center Provide New Insights into Pancreatic Cancer [The interim analysis of a single-arm, open-label, phase II study investigating ALLEN regimen (durvalumab plus albumin paclitaxel and lenvatinib) in patients...].
In: Immunotherapy Weekly, 2024-02-08, S. 1295-1295
serialPeriodical
Zugriff:
Titel: |
Study Findings from First Medical Center Provide New Insights into Pancreatic Cancer [The interim analysis of a single-arm, open-label, phase II study investigating ALLEN regimen (durvalumab plus albumin paclitaxel and lenvatinib) in patients...].
|
---|---|
Zeitschrift: | Immunotherapy Weekly, 2024-02-08, S. 1295-1295 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1090-8625 (print) |
Sonstiges: |
|